Tuesday, September 05, 2017 8:47:43 AM
BLPH - 1.13 Pre-market now at 1.28/1.32
MW Bellerophon shares surge 20% premarket on positive results in trial of COPD treatment
Bellerophon Announces Positive Top Line Phase 2 Data of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
MW Bellerophon shares surge 20% premarket on positive results in trial of COPD treatment
Bellerophon Announces Positive Top Line Phase 2 Data of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
